ITHUF

iANTHUS CAPITAL HOLDINGS, INC.
3 filings tracked
healthcarecannabis operationsMICRO (<$300M)

Signal Magnitude Chart

BULLISH | 70% | 3/27/2026 | debt restructureBEARISH | 30% | 3/27/2026 | margin compressionBEARISH | 90% | 3/27/2026 | dilution riskBULLISH | 60% | 3/27/2026 | divestitureBEARISH | 80% | 5/12/2026 | earnings missBULLISH | 60% | 5/12/2026 | margin expansionBEARISH | 50% | 5/12/2026 | dilution riskBULLISH | 90% | 5/12/2026 | regulatory actionBEARISH | 80% | 5/12/2026 | earnings missBULLISH | 60% | 5/12/2026 | margin expansionBEARISH | 50% | 5/12/2026 | dilution riskBULLISH | 90% | 5/12/2026 | regulatory actionMar 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bearishMay 12

Net loss widened to $14.3 million for the quarter compared to a net income of $5.15 million in the prior year period.

earnings miss
80%
bullishMay 12

Emerging region gross margins increased to 45.4% driven by higher-margin toll-processing arrangements.

margin expansion
60%
bearishMay 12

Significant debt is structured as paid-in-kind interest, inflating the principal and increasing future repayment pressure.

dilution risk
50%
bullishMay 12

Federal rescheduling of medical cannabis to Schedule III potentially removes Section 280E tax barriers.

regulatory action
90%
bearishMay 12

Net loss widened to $14.3 million for the quarter compared to a net income of $5.15 million in the prior year period.

earnings miss
80%
bullishMay 12

Emerging region gross margins increased to 45.4% driven by higher-margin toll-processing arrangements.

margin expansion
60%
bearishMay 12

Significant debt is structured as paid-in-kind interest, inflating the principal and increasing future repayment pressure.

dilution risk
50%
bullishMay 12

Federal rescheduling of medical cannabis to Schedule III potentially removes Section 280E tax barriers.

regulatory action
90%
bullishMar 27

Extended bridge note maturities to 2027 and reduced interest rates on secured debt.

debt restructure
70%
bearishMar 27

Gross margins declined slightly from 46.8% to 45.7% amid pricing pressures.

margin compression
30%
bearishMar 27

Massive RSU grants totaling $165M create significant future equity dilution.

dilution risk
90%
bullishMar 27

Exited Arizona and Nevada markets to recycle capital into the eastern corridor.

divestiture
60%

Filing History

10-QMay 12, 2026

The latest 10-Q reveals a company at a critical crossroads, attempting to outrun a massive debt load through a strategic geographic pivot. On one hand, the shift toward 'Emerging' markets is showing early signs of success in terms of revenue growth and gross margin improvement. On the other hand, the company's reliance on related-party debt and its struggle with a massive accumulated deficit of $1.39 billion create a high-risk profile for equity holders. The most significant variable for investors is the intersection of federal rescheduling and the company's liquidity. While the move to Schedule III could theoretically solve the tax-driven margin compression, the immediate reality is a working capital deficiency of $21.9 million and a management team that has explicitly stated there is substantial doubt about the company's ability to continue as a going concern for the next 12 months. The trade-off is clear: iAnthus offers high-convexity upside if federal reform triggers a valuation re-rating, but it carries an extreme risk of insolvency if it cannot secure additional capital or resolve its tax liens.

10-KMar 27, 2026

The iAnthus 10-K reveals a company in the midst of a high-stakes transformation. The operational pivot to the eastern corridor and the successful restructuring of short-term debt have provided a narrow window of survival. However, the company remains tethered to a massive debt load and a history of litigation that continues to drain cash reserves. The ultimate trajectory of the investment hinges on a binary regulatory catalyst. Federal rescheduling to Schedule III would unlock massive deferred tax assets and eliminate the restrictive 280E tax burden, potentially transforming the company's thin cash flow into significant profitability. Without this catalyst, the company faces a daunting 2027 debt maturity that may force further dilutive capital raises or a structured bankruptcy.